Form 4: Varonis CFO Sells Shares Under Pre-Arranged 10b5-1 Plan

Sentiment:

Insider Transaction Report


Varonis Systems CFO and COO Guy Melamed sold 5,392 shares of common stock in late August 2025, pursuant to a Rule 10b5-1 trading plan adopted in 2024.

Summary

  • Guy Melamed, the Chief Financial Officer and Chief Operating Officer of Varonis Systems Inc. (VRNS), reported sales of the company's common stock.
  • On August 28, 2025, Mr. Melamed sold 3,892 shares of common stock at a weighted average price of $59.52 per share.
  • On August 29, 2025, an additional 1,500 shares of common stock were sold at a weighted average price of $59.59 per share.
  • These transactions were executed under a Rule 10b5-1 trading plan, which Mr. Melamed adopted in 2024.
  • Following these sales, Mr. Melamed's direct beneficial ownership of Varonis Systems common stock stands at 412,105 shares.
  • The total number of shares sold across both transactions amounts to 5,392.

Sentiment

Score: 5

Explanation: The insider sale was executed under a pre-arranged 10b5-1 plan, indicating a planned transaction for personal financial management rather than a reaction to new, undisclosed company information. This typically results in a neutral market perception.

Positives

  • The sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned transaction for personal financial management rather than a reaction to new, undisclosed company information, which enhances transparency.

Negatives

  • Insider selling, even if planned, can sometimes be perceived by the market as a lack of confidence, though the impact is significantly mitigated by the pre-established 10b5-1 plan.

Risks

  • There is a potential for negative market perception if investors misinterpret the planned sale as a signal of deteriorating company performance, despite the 10b5-1 plan.

Stakeholder Impact

  • Shareholders may note the insider sale, but the pre-arranged nature under a 10b5-1 plan generally mitigates concerns about management's confidence in the company's future, suggesting a neutral impact.

Key Dates

DateDescription
2024Rule 10b5-1 trading plan adopted by Guy Melamed.
08/28/2025Sale of 3,892 shares of common stock at a weighted average price of $59.52 per share.
08/29/2025Sale of 1,500 shares of common stock at a weighted average price of $59.59 per share.
09/02/2025Date of filing and signature by attorney-in-fact.

Recommendation

hold

The reported insider sales by CFO and COO Guy Melamed were conducted under a pre-arranged Rule 10b5-1 trading plan. Such plans are established in advance to allow insiders to sell shares without being accused of trading on material non-public information. Given the planned nature of the sales and the relatively small percentage of total holdings sold (approximately 1.3%), this transaction is unlikely to signal a change in the company's fundamental outlook or warrant a shift in investment strategy. Therefore, a 'hold' recommendation is appropriate, as the filing does not present new information that would significantly alter the investment thesis.

Keywords

Varonis Systems, VRNS, Insider Trading, Form 4, Stock Sale, Guy Melamed, CFO, COO, 10b5-1 Plan, Equity Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.